(Total Views: 717)
Posted On: 11/10/2020 12:19:24 AM
Post# of 157795
I’m sorry but maybe it will be sooner ?
I’m not messing around but I don’t know a single person who has it right now. The news is saying numbers are increasing but there is no sign of that here. We have had a few more cases because a lot more testing due to cold season but nobody I know. We also haven’t had a single death here in awhile?
I’m just confused because things are not adding up to what the media is saying. Now that I’m back to work I’ve been at the hospitals a lot for MHAs and most people said they aren’t having any issues.
Maybe my city is lucky? Anyone in the medical field seeing a lot of new cases or anything ?
I’m not messing around but I don’t know a single person who has it right now. The news is saying numbers are increasing but there is no sign of that here. We have had a few more cases because a lot more testing due to cold season but nobody I know. We also haven’t had a single death here in awhile?
I’m just confused because things are not adding up to what the media is saying. Now that I’m back to work I’ve been at the hospitals a lot for MHAs and most people said they aren’t having any issues.
Maybe my city is lucky? Anyone in the medical field seeing a lot of new cases or anything ?


Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://firegatebiotech.com/2025
FG-001: Integrated Triplet Immunotherapy for Functional HIV Cure
FG-002: Triplet Immunologic Modulation in Oncology — NF-κB / IL-1Ra Axis
FG-003: Neuro-Immune Repair Triplet — Concept and Combination Framework
CCR5 Antagonists & Triplet Immunotherapy Synergy in HIV
HIV Cure Pathways — Functional-Cure Framework Overview
FG-003 Neuro-Immune Repair Triplet — IP & Combination Strategy
— Jeremiah 51:36